C
SLNO

Covestor’s Soleno Therapeutics SLNO Stock Holding History

Covestor’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed – – 2809
2026
Q1 		$0 Buy
4
+2
+100% +$78 ﹤0.01% 2726
2025
Q4 		$0 Hold
2
– – ﹤0.01% 2696
2025
Q3 		$0 Hold
2
– – ﹤0.01% 2725
2025
Q2 		$0 Hold
2
– – ﹤0.01% 2707
2025
Q1 		$0 Hold
2
– – ﹤0.01% 2685
2024
Q4 		$0 Hold
2
– – ﹤0.01% 2690
2024
Q3 		$0 Buy
+2
New +$96 ﹤0.01% 2713

Covestor's SLNO Position: Q2 2026 in Review

Covestor sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 4 shares.

Covestor first reported a position in SLNO in Q3 2024 and held it in 7 quarters. The position peaked at $0 in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

  • Covestor reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Covestor sold 4 Soleno Therapeutics shares in Q2 2026.
  • Covestor first reported a position in Soleno Therapeutics in Q3 2024 and held it in 7 quarters.
  • Covestor's Soleno Therapeutics position peaked at $0 in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.